Skip to main content
. 2019 Nov 9;112(8):802–809. doi: 10.1093/jnci/djz223

Table 2.

Descriptive characteristics, metastatic non–small cell lung cancer, SEER-Medicare, 2007–2015, N = 10 655

Variables Monthly drug cost
Residency
< $5000 N = 3528 ≥$5000 N = 7127 P * Rural N = 1287 Urban N = 9354 P *
Age, y
 66–75 2118 (60.0) 4292 (60.2) .19 876 (68.1) 5524 (59.1) < .001
 76–85 1254 (35.5) 2466 (34.6) 384 (29.8) 3333 (35.6)
 86 and older 156 (4.4) 369 (5.2) 27 (2.1) 497 (5.3)
Sex
 Female 1735 (49.2) 3897 (54.7) < .001 621 (48.3) 5006 (53.5) < .001
 Male 1793 (50.8) 3230 (45.3) 666 (51.7) 4348 (46.5)
Race/Ethnicity
 White non-Hispanic 2895 (82.1) 5620 (78.9) < .001 1184 (92.0) 7321 (78.3) < .001
 Black non-Hispanic 291 (8.2) 474 (6.7) 47 (3.7) 717 (7.7)
 Hispanic 195 (5.5) 383 (5.4) 31 (2.4) 544 (5.8)
 Other/unknown 147 (4.2) 650 (9.1) 25 (1.9) 772 (8.3)
Census tract percentage below poverty
 < 20% poverty 2630 (74.9) 5662 (79.6) < .001 787 (61.3) 7498 (80.4) < .001
 .≥20% poverty 882 (25.1) 1452 (20.4) 497 (38.7) 1831 (19.6)
Rurality
 Urban 3012 (85.5) 6342 (89.1) < .001 N/A N/A
 Rural 510 (14.5) 777 (10.9)
Comorbidities
 0 1243 (35.2) 2961 (41.5) < .001 488 (37.9) 3707 (39.6) .30
 1 1039 (29.5) 2131 (29.9) 406 (31.5) 2762 (29.5)
 2 or more 1246 (35.3) 2035 (28.6) 393 (30.5) 2885 (30.8)
Treated at an NCI-designated center
 No/unknown 3029 (85.9) 5452 (76.5) < .001 1087 (84.5) 7381 (78.9) < .001
 Yes 499 (14.1) 1675 (23.5) 200 (15.5) 1973 (21.1)
Medical school–affiliated hospital in county
 No 1276 (36.2) 2061 (28.9) < .001 1064 (82.7) 2264 (24.2) < .001
 Yes 2250 (63.8) 5064 (71.1) 223 (17.3) 7086 (75.8)
High-cost drug
 < $5000/month N/A N/A 510 (39.6) 3012 (32.2) < .001
 ≥ $5000/month 777 (60.4) 6342 (67.8)
Year of diagnosis
 2007 544 (15.4) 500 (7.0) < .001 128 (9.9) 915 (9.8) .24
 2008 473 (13.4) 574 (8.1) 140 (10.9) 901 (9.6)
 2009 407 (11.5) 701 (9.8) 125 (9.7) 980 (10.5)
 2010 354 (10.0) 677 (9.5) 129 (10.0) 901 (9.6)
 2011 362 (10.3) 734 (10.3) 128 (9.9) 967 (10.3)
 2012 366 (10.4) 885 (12.4) 176 (13.7) 1, 075 (11.5)
 2013 361 (10.2) 1020 (14.3) 163 (12.7) 1218 (13.0)
 2014 344 (9.8) 1033 (14.5) 149 (11.6) 1228 (13.1)
 2015 317 (9.0) 1003 (14.1) 149 (11.6) 1169 (12.5)
Total Medicare spending 12 months following diagnosis§ 58 880 93 953 < .001 67 580 84 394 < .001
 Inpatient 27 946 25 400 < .001 19 812 27 122 < .001
 Outpatient hospital 8885 22 273 <.001 19 188 17 666 < .001
Professional 14 877 29 701 < .001 18 966 25 601 < .001
 Durable medical equipment 585 560 .59 610 562 .26
 Prescription medications 2 264 11 980 < .001 5 576 9 212 < .001
 Hospice 2807 2125 < .001 2157 2380 .11
 Home health 1516 1913 < .001 1271 1851 < .001
*

Two-sided P values were calculated using the chi-square test. Percentage of sample size is shown in parentheses. N/A = not applicable; NCI = National Cancer Institute; SEER = Surveillance, Epidemiology, and End-Results.

Area-level poverty is defined at the census tract when available. For observations missing the census tract, area-level poverty is defined at the zip code. Twenty-eight observations were missing census tract data.

Urban/rural classification is based on the U.S. Department of Agriculture’s Rural Urban Commuting Area Codes.

§

Medicare spending is for 12 months following the month of diagnosis.